{
    "nctId": "NCT06187103",
    "briefTitle": "Evaluation of Improved Onboard Patient Imaging",
    "officialTitle": "Evaluation of Improved Onboard Patient Imaging With the HyperSight Platform on TrueBeam 4.1",
    "overallStatus": "RECRUITING",
    "conditions": "Head and Neck Cancer, Breast Cancer, Upper Gastrointestinal Cancer, Lung Cancer, Pelvic Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "Fraction of patients whose HyperSight CBCT images meet the criteria for CBCT-based treatment planning.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patient is willing and able to provide written consent.\n2. Patient is at least 18 years of age at the time of consent.\n3. Patient has biopsy confirmed malignancy and recommendation for definitive or palliative radiation to the head and neck, breast, lungs, upper GI structures, or pelvis.\n4. Patient has ECOG performance status 0-2.\n5. Patient will be receiving radiation therapy at University of Maryland Medical Center, Department of Radiation Oncology.\n\nExclusion Criteria:\n\n1. Patient is pregnant or attempting pregnancy.\n2. Patient has implanted cardiac devices or nerve stimulation devices.\n3. Patient has known genetic pre-disposition for sensitivity to radiation (e.g., Li Fraumeni).\n4. Patient receives palliative radiation for 5 or fewer fractions.\n5. Patient is part of a vulnerable population (per ISO 14155:2020, \"individuals who are unable to fully understand all aspects of the investigation that are relevant to the decision to participate, or who could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliatory response\"). This includes prisoners.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}